BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 21849)

  • 1. Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV.
    Giebink GS; Verhoef J; Peterson PK; Quie PG
    Infect Immun; 1977 Nov; 18(2):291-7. PubMed ID: 21849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay.
    Matthay KK; Mentzer WC; Wara DW; Preisler HK; Lameris NB; Ammann AJ
    Infect Immun; 1981 Jan; 31(1):228-35. PubMed ID: 7216447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of antibody concentration on opsonic requirements for phagocytosis in vitro of Streptococcus pneumoniae types 7 and 19.
    Chudwin DS; Wara DW; Lameris-Martin NB; Ammann AJ
    Proc Soc Exp Biol Med; 1983 Feb; 172(2):178-86. PubMed ID: 6402784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.
    Verbrugh HA; Van Dijk WC; Peters R; Van Der Tol ME; Peterson PK; Verhoef J
    Immunology; 1979 Mar; 36(3):391-7. PubMed ID: 108204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum opsonic deficiency produced by Streptococcus pneumoniae and by capsular polysaccharide antigens.
    Giebink GS; Grebner JV; Kim Y; Quie PG
    Yale J Biol Med; 1978; 51(5):527-38. PubMed ID: 34937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.
    Verhoef J; Peterson P; Kim Y; Sabath LD; Quie PG
    Immunology; 1977 Aug; 33(2):191-7. PubMed ID: 415969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsonization of four Bacteroides species: role of the classical complement pathway and immunoglobulin.
    Tofte RW; Peterson PK; Schmeling D; Bracke J; Kim Y; Quie PG
    Infect Immun; 1980 Mar; 27(3):784-92. PubMed ID: 6103873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opsonic activity of normal human cerebrospinal fluid for selected bacterial species.
    Tofte RW; Peterson PK; Kim Y; Quie PG
    Infect Immun; 1979 Dec; 26(3):1093-8. PubMed ID: 43289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte phagocytosis and killing virulent and avirulent serotypes of Streptococcus pneumoniae.
    Braconier JH; Odeberg H
    J Lab Clin Med; 1982 Aug; 100(2):279-87. PubMed ID: 6284848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsonization of group B streptococci in properdin deficient serum.
    Söderström C; Braconier JH; Christensen KK; Christensen P; Sjöholm AG
    Acta Pathol Microbiol Immunol Scand C; 1985 Dec; 93(6):251-6. PubMed ID: 3915179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte phagocytosis of Streptococcus pneumoniae in properdin-deficient serum.
    Braconier JH; Odeberg H; Sjöholm AG
    Infect Immun; 1983 Apr; 40(1):219-24. PubMed ID: 6403465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Streptococcus pneumoniae type XIV opsonins by phagocytosis-associated chemiluminescence and a bactericidal assay.
    Gardner SE; Anderson DC; Webb BJ; Stitzel AE; Edwards MS; Spitzer RE; Baker CJ
    Infect Immun; 1982 Mar; 35(3):800-8. PubMed ID: 6802760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the alternate complement pathway in opsonization of several bacterial species.
    Forsgren A; Quie PG
    Infect Immun; 1974 Aug; 10(2):402-4. PubMed ID: 4152919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opsonization and phagocytosis of mucoid and non-mucoid Pseudomonas aeruginosa strains.
    Meshulam T; Verbrugh HA; Verhoef J
    Eur J Clin Microbiol; 1982 Apr; 1(2):112-7. PubMed ID: 6816585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for quantitative variability of bacterial opsonic requirements.
    Guckian JC; Christensen WD; Fine DP
    Infect Immun; 1978 Mar; 19(3):822-6. PubMed ID: 25243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiencies in opsonic defense to pneumococci in the human newborn despite adequate levels of complement and specific IgG antibodies.
    Geelen SP; Fleer A; Bezemer AC; Gerards LJ; Rijkers GT; Verhoef J
    Pediatr Res; 1990 May; 27(5):514-8. PubMed ID: 2345679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-dependent alternate pathway of complement activation in opsonophagocytosis of Porphyromonas gingivalis.
    Cutler CW; Kalmar JR; Arnold RR
    Infect Immun; 1991 Jun; 59(6):2105-9. PubMed ID: 2037371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular trafficking and killing of Streptococcus pneumoniae by human alveolar macrophages are influenced by opsonins.
    Gordon SB; Irving GR; Lawson RA; Lee ME; Read RC
    Infect Immun; 2000 Apr; 68(4):2286-93. PubMed ID: 10722631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum heat-labile opsonins in systemic lupus erythematosus.
    Jasin HE; Orozco JH; Ziff M
    J Clin Invest; 1974 Feb; 53(2):343-53. PubMed ID: 11344546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between serum opsonic activity for Streptococcus pneumoniae and complement function in sickle cell disease.
    Bjornson AB; Lobel JS; Harr KS
    J Infect Dis; 1985 Oct; 152(4):701-9. PubMed ID: 3930618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.